ITLN1 and hepatocellular carcinoma: Thirdly, being limited by scientific research funds and experimental technologies, we have not completed the application of purified ITLN1 protein in animal models, which makes the article lack more advanced evidence supporting the therapeutic value of ITLN1 in HCC.